4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-032078
Chief Executive Officer sold 30,000 shares at an average $34.58 ($1,037,361)
From the SEC's structured data for this filing
Trades in this filing
Lynch Casey · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-10 | Sale : show line 1 in the form | −13,584 | $33.75 | $458,460 | 995,190 | I |
| 2021-05-10 | Sale : show line 2 in the form | −9,918 | $34.89 | $346,039 | 985,272 | I |
| 2021-05-10 | Sale : show line 3 in the form | −6,315 | $35.81 | $226,140 | 978,957 | I |
| 2021-05-10 | Sale : show line 4 in the form | −183 | $36.73 | $6,722 | 978,774 | I |
| Open-market sales · 30,000 sh · avg $34.58 · $1,037,361 | ||||||
Loading xslF345X03/doc4.xml…